Ga onbeperkt met Magzter GOLD

Ga onbeperkt met Magzter GOLD

Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts

$149.99
 
$74.99/Jaar

Poging GOUD - Vrij

The world is winning the war on cancer

Mint Mumbai

|

July 19, 2025

In 1971 Richard Nixon, then America's president, announced a "war on cancer".

The world is winning the war on cancer

Just two years earlier the Apollo programme had combined big science and big government to put astronauts on the moon, so hopes were high. Some optimistic doctors talked of a cure for cancer within a few years.

They were wrong. Today every adult has had cancer, knows someone who has, or both. Half of men and a third of women in rich countries can expect to suffer from it at some point in their lives. In America, where it is the second-most-common cause of death, just behind heart disease, it kills around 600,000 people a year. Worldwide, it is responsible for about one in six of all deaths. If your criterion for success was a cure within a decade or even two or three or four-then you might conclude that the war on cancer has been lost.

In fact, things are better than many realize. The progress is plain from the data and there is every reason to think it will continue. Cancer is related to age. If you strip out longer lifespans, it becomes clear that in the rich world the early 1990s were an inflection point. Since then, the age-adjusted death rate has been falling, slowly but steadily, year after year. In America the rate is now about a third lower than in the 1990s. The trend is similar in other developed countries.

What some scientists hoped would be a blitzkrieg has turned out to be a steady but successful war of attrition. Some victories have been spectacular. Childhood leukaemia used to be virtually a death sentence; now it has a five-year survival rate above 90%. Yet because cancer is not one illness, but a whole category, much of the progress has come not from big breakthroughs, but thousands of smaller advances in screening, surgery and drugs.

MEER VERHALEN VAN Mint Mumbai

Mint Mumbai

These firms will sell shovels during semaglutide gold rush

Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.

time to read

1 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

EV, hydro boom to power 6x rise in battery storage by ‘47

India is preparing to meet a projected cumulative battery energy storage capacity of nearly 3 terawatt-hours (TWh) by 2047 across electric mobility, power, and electronic components, according to two people aware of the development, with electric vehicles (EVs) expected to contribute a third of the demand.

time to read

2 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Candidates using AI? No, thanks, say IIT recruiters

As the annual placement season dawns at the Indian Institutes of Technology (IITs), colleges and recruiters are working to bar artificial intelligence (AI) tools and prevent cheating at test venues, a concern that first rose last year.

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Taxpayer base soars, but return filings lag sharply: CBDT data

India’s income tax base is growing faster than the number of those conscientiously filing returns, driven by the expanding reach of the tax deducted at source (TDS) system, according to latest data from the central board of direct taxes (CBDT).

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Market nears peak on dollar tailwind

Stocks jump 1.2%, but futures rollovers signal weak conviction

time to read

3 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

SP Eyes Tata exit to cut debt costs

Debt-laden Shapoorji Pallonji Group is banking on Tata Trusts softening the stance on its potential exit from Tata Sons to reduce its borrowing costs, two people aware of the matter said.

time to read

2 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Reliance JV, L&T to plough $13.5 bn into data centres

India’s data-infrastructure buildout hit a $13.5-billion inflection point on Wednesday, with a Reliance Industries Ltd (RIL) joint venture and Larsen & Toubro (L&T) announcing large-scale investments in data centres, driven by surging demand for artificial intelligence (AI) applications.

time to read

2 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

Citi's asset-backed India securities book nears $1 bn

Citigroup Inc.'s India unit has more than doubled its asset-backed securities book to nearly $1 billion in the last two years, ahead of schedule for a goal it set for itself in February.

time to read

1 mins

November 27, 2025

Mint Mumbai

Mint Mumbai

INSIDE THE QUIET RISE OF A GURUGRAM DEVELOPER

Rising from the ashes of NCR's property crisis, Signature Global became India’s 5th-largest listed realty firm in FY25 by sales

time to read

7 mins

November 27, 2025

Mint Mumbai

Europe bets on $25 bn space budget amid defence hike

Europe’s equivalent of NASA is seeking €22 billion ($25.

time to read

1 min

November 27, 2025

Listen

Translate

Share

-
+

Change font size